WuXi PharmaTech (Cayman) Inc. Announces Filing of Registration Statement For Follow-On and Secondar... (eunlawful prior to registration or quali...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

WuXi PharmaTech (Cayman) Inc. Announces Filing of Registration Statement For Follow-On and Secondary Offering

Date:4/4/2008

e unlawful prior to registration or qualification under the securities laws of any such state.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device research and development, or R&D, outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the R&D process to pharmaceutical, biotechnology and medical device companies. WuXi PharmaTech's services are designed to assist our global customers in shortening the time and lowering the cost of drug and medical device R&D by providing cost-effective and efficient outsourcing solutions. For more information, please visit http://www.wuxipharmatech.com.

Contact:

Sherry Shao

WuXi PharmaTech

Tel: +86 (21) 5046-4002

SOURCE WuXi PharmaTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results
2. WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, March 12, 2008
3. WuXi PharmaTech Completes Acquisition of AppTec
4. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
5. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
6. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
7. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
8. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
9. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
10. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
11. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia

Post Your Comments:

Breaking Biology Technology:New technology could boost disease detection tests' speed and sensitivity 2 Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2 Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer 2 BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 2 BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 3

[0] New technology could boost disease detection tests' speed and sensitivity [0] Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry [0] Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer [0] BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement

Other Biology Technology:CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 2 CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 3 CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 4 CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection 5 Vermillion Announces Appointment of John Hamilton to Board of Directors 2 Amnis Announces Release of Powerful New Image Data Analysis Software 2

CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection Vermillion Announces Appointment of John Hamilton to Board of Directors Amnis Announces Release of Powerful New Image Data Analysis Software

Breaking Biology News(10 mins):Self-destructing bacteria improve renewable biofuel production 2 Self-destructing bacteria improve renewable biofuel production 3 Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2 $2.4 million stimulus fuels effort to regenerate injured spinal cords 2 $2.4 million stimulus fuels effort to regenerate injured spinal cords 3 $2.4 million stimulus fuels effort to regenerate injured spinal cords 4 Technology guide 3A Principles applications trends 8858 1 Technology guide 3A Principles applications trends 8858 2 Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 1 Reportable Food Registry Draft Guidance Published for Comment by FDA 49058 2 Video 3A BeautyScoop 28R 29 Is a Trip to Your Nutritionist and Dermatologist in One Single Packet Lauren Slayton NYC Nutritionist 26 Owner of FoodT 49053 1 Video 3A BeautyScoop 28R 29 Is a Trip to Your Nutritionist and Dermatologist in One Single Packet Lauren Slayton NYC Nutritionist 26 Owner of FoodT 49053 2

[0] Self-destructing bacteria improve renewable biofuel production [0] Researchers demonstrate nanoscale X-ray imaging of bacterial cells [0] $2.4 million stimulus fuels effort to regenerate injured spinal cords

Other Biology News:Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes 2 Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes 3 Temperament linked to onset of cancer and early death in female rats 2 Coral reefs are increasingly vulnerable to angry oceans 2 Coral reefs are increasingly vulnerable to angry oceans 3

Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes Temperament linked to onset of cancer and early death in female rats Coral reefs are increasingly vulnerable to angry oceans

Biology Products:

cAMP[125I] Direct SPA Screening Biotrak Assay from GE Healthcare, formerly Amersham Biosciences Rabbit Anti-Human ASIP / PAR3 Monoclonal Antibody, Clone ZMD.283 from Invitrogen BioPrime Array CGH Genomic Labeling Module from Invitrogen pLenti6/V5-DEST Gateway Vector from Invitrogen